Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score-Reference-Cited by-同舟云学术

Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score

Published:2019-02-27 Issue:2 Volume:14 Page:e0211721
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Simon Marie,Bosset Pierre-Olivier,Rouanne Mathieu,Benhamou Simone,Radulescu Camelia,Molinié Vincent,Neuzillet Yann,Paoletti Xavier^ORCID,Lebret Thierry

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;J Ferlay;Int J Cancer,2015

2. Rouprêt M, Neuzillet Y, Masson-Lecomte A, Colin P, Compérat E, Dubosq F, Houédé N, Larré S, Pignot G, Puech P, Roumiguié M, Xylinas E, Méjean A. CCAFU french national guidelines 2016–2018 on bladder cancer.

3. Recommendations Onco-Urology 2010: Urothelial tumors;C Pfister;Prog Urol,2010

4. Bladder cancer;MA Kamat;Lancet,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of office-based diode laser ablation for recurrent low-grade non-muscle-invasive bladder cancer under local anaesthesia: A pilot study;Arab Journal of Urology;2024-07-18

2. Mitomycin C vs. Bacillus Calmette–Guerin for treatment of intermediate-risk nonmuscle invasive bladder cancer patients—A comparative analysis from a single center;Urologic Oncology: Seminars and Original Investigations;2024-07

3. Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over Time;Urology;2024-07

4. The International Bladder Cancer Group Intermediate-Risk Non-muscle Invasive Bladder Cancer Scoring System Predicts the Need for Intervention for Patients on Active Surveillance;EMJ Urology;2024-05-16

5. International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance;Journal of Urology;2023-11